Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to -$2.7 million.

  • IceCure Medical's Free Cash Flow rose 1342.52% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.7 million, marking a year-over-year decrease of 3029.93%. This contributed to the annual value of -$12.5 million for FY2024, which is 349.63% down from last year.
  • As of Q3 2025, IceCure Medical's Free Cash Flow stood at -$2.7 million, which was up 1342.52% from -$2.8 million recorded in Q2 2025.
  • IceCure Medical's 5-year Free Cash Flow high stood at -$1.5 million for Q2 2021, and its period low was -$6.8 million during Q4 2021.
  • Over the past 5 years, IceCure Medical's median Free Cash Flow value was -$3.0 million (recorded in 2022), while the average stood at -$3.3 million.
  • Per our database at Business Quant, IceCure Medical's Free Cash Flow crashed by 28687.96% in 2021 and then surged by 6173.84% in 2023.
  • IceCure Medical's Free Cash Flow (Quarter) stood at -$6.8 million in 2021, then grew by 14.33% to -$5.8 million in 2022, then skyrocketed by 61.74% to -$2.2 million in 2023, then tumbled by 88.48% to -$4.2 million in 2024, then surged by 35.51% to -$2.7 million in 2025.
  • Its last three reported values are -$2.7 million in Q3 2025, -$2.8 million for Q2 2025, and -$4.0 million during Q1 2025.